Recruiting Pulmonary Embolism Studies in Wilmington
Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
The primary objective of this study is to evaluate the effect of romosozumab treatment for 12-months compared with bisphosphonate(s) on the number of clinical fractures at 12-months; the number of any...
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
The primary objective of this study is to evaluate the dose effect of Phenylephrine Hydrochloride Injection on the treatment of clinically relevant decreased blood pressure in the pediatric population...
About Pulmonary Embolism Clinical Trials in Wilmington
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Wilmington, NORTH%20CAROLINA. These studies are seeking a combined 206 participants. Research is being sponsored by Amgen, West-Ward Pharmaceutical. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Wilmington — FAQ
Are there pulmonary embolism clinical trials in Wilmington?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Wilmington, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Wilmington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wilmington research site will contact you about next steps.
Are clinical trials in Wilmington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wilmington studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Wilmington are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov